Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.
Clin Cancer Res. 2024 Jun 3;30(11):2514-2530. doi: 10.1158/1078-0432.CCR-23-3504.
Clin Cancer Res. 2024.
PMID: 38252421
Free PMC article.
High Level of Pre-Treatment HIV-1 Drug Resistance and Its Association with HLA Class I-Mediated Restriction in the Pumwani Sex Worker Cohort.
Willim R, Shadabi E, Sampathkumar R, Li L, Balshaw R, Kimani J, Plummer FA, Luo M, Liang B.
Willim R, et al.
Viruses. 2022 Jan 28;14(2):273. doi: 10.3390/v14020273.
Viruses. 2022.
PMID: 35215866
Free PMC article.
Item in Clipboard
A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic score.
Phillips AA, Shapira I, Willim RD, Sanmugarajah J, Solomon WB, Horwitz SM, Savage DG, Bhagat G, Soff G, Zain JM, Alobeid B, Seshan VE, O'Connor OA.
Phillips AA, et al. Among authors: willim rd.
Cancer. 2010 Jul 15;116(14):3438-46. doi: 10.1002/cncr.25147.
Cancer. 2010.
PMID: 20564100
Free article.
Item in Clipboard
A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of relapsed patients.
Phillips AA, Willim RD, Savage DG, Horwitz SM, Isola L, Zain JM, O'Connor OA.
Phillips AA, et al. Among authors: willim rd.
Leuk Lymphoma. 2009 Jun;50(6):1039-42. doi: 10.1080/10428190902887571.
Leuk Lymphoma. 2009.
PMID: 19373596
No abstract available.
Item in Clipboard
Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies.
O'Connor OA, Heaney ML, Schwartz L, Richardson S, Willim R, MacGregor-Cortelli B, Curly T, Moskowitz C, Portlock C, Horwitz S, Zelenetz AD, Frankel S, Richon V, Marks P, Kelly WK.
O'Connor OA, et al. Among authors: willim r.
J Clin Oncol. 2006 Jan 1;24(1):166-73. doi: 10.1200/JCO.2005.01.9679. Epub 2005 Dec 5.
J Clin Oncol. 2006.
PMID: 16330674
Item in Clipboard
Cite
Cite